Home » Health News » Currently Reading:

Final Data From Phase 2 Study Confirm High Response Rate Of Micromet’s Blinatumomab In Patients With Acute Lymphoblastic Leukemia

December 9, 2009 Health News No Comments

Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL). The data were presented in an oral presentation(1) at the 51st Annual Meeting of the American Society of Hematology (ASH) and were selected by the Society for inclusion in its “Best of ASH” session…

Go to Source

People who read this also read

ADS:

Related Articles:

Heart Disease And Stroke Survivors Urge Congress To Increase Funding For The National Institutes Of Health

March 12, 2010

Enhance National Institutes of Health (NIH)-supported research to improve health, spur economic growth and innovation and science. American Heart Association patient advocates and researchers today delivered that message to members of Congress during the association’s Research Saves Lives Fly-In Lobby Day. Many heart disease and stroke survivors have benefited from advances as a result of NIH-supported research. However, despite progress and promising research opportunities, there is still no cure for heart disease or stroke…

Go to Source… Continue reading

Stem Cell Therapeutics Corp. Announces Publication Of Phase IIa Stroke Data

March 12, 2010

Stem Cell Therapeutics Corp. (“SCT” or the “Company”) (TSX VENTURE:SSS) wishes to announce the acceptance and publication of the paper entitled “The Beta-hCG + Erythropoietin in Acute Stroke ( BETAS) Study” by the journal “Stroke”, on March 8, 2010. This paper was authored by Dr. Steven C. Cramer, from the University of California, Irvine, Dr. David Brown at Hoag Memorial Hospital Presbyterian, New Port Beach, Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and colleagues. Dr…

Go to Source… Continue reading

Wilson Disease

March 12, 2010

Wilson disease is an inherited condition that causes the body to retain excess copper. The liver of a person who has Wilson’s disease does not release copper into bile as it should. As the copper builds up in the liver, it begins to damage the organ.

After enough damage, the liver releases the copper directly into the bloodstream, which carries the copper throughout the body. The copper buildup leads to damage in the kidneys, brain, and eyes. If not treated, Wilson’s disease can cause severe brain damage, liver failure, and death.

What are the symptoms of Wilson disease?

Wilson… Continue reading

Rhode Island Congressman Patrick Kennedy Recognized For Advocacy Work On Mental Health Issues

March 12, 2010

Congressman Patrick J. Kennedy (D-RI) was honored last night by the American Psychological Association for his advocacy work and legislative accomplishments on mental health issues. The APA presented Kennedy with the 2010 Outstanding Leadership Award, given annually to a member of Congress who has prominently championed the goals of professional psychology. “Congressman Kennedy has been a tireless crusader of mental health rights,” says Katherine C. Nordal, PhD, APA executive director for professional practice…

Go to Source… Continue reading

Congress, Obama Continue Health Reform Push

March 12, 2010

“Health care reform takes center stage Thursday as President Obama and top congressional Democrats work behind closed doors to nail down a final agreement,” CNN reports. House Speaker Nancy Pelosi, D-Calif., hosted a “meeting of the entire House Democratic caucus in the morning,” while Senate Majority Leader Harry Reid plans to hold a news conference that will “build public momentum by framing the issue in more personal terms.” Reid told reporters today that he believes progress is being made.  ”‘I really believe the goal we’ve been seeking for a long time of health care reform is going to be done. We don’t have… Continue reading

Comment on this Article:







Security Code: